Schizophrenia spectrum disorders in people with intellectual disabilities.
OBJECTIVE
To examine most recently published studies of schizophrenia spectrum disorders in people with intellectual disabilities.


RESULTS
Studies that have been published in the review period have advanced understanding of the epidemiology, presentation, assessment, suspected neuropathology, genetics and treatment of, and service issues relating to, schizophrenia spectrum disorders in people with intellectual disabilities.


CONCLUSIONS
The number of published studies investigating schizophrenia spectrum disorders in people with intellectual disabilities continues to increase slowly. The evidence base, however, needs to be strengthened, particularly by randomized controlled trials in pharmacotherapy, psychosocial interventions and service delivery.
Hemmings
Colin P
CP
Estia Centre, Institute of Psychiatry, King's College London, London, UK. Colin.Hemmings@slam.nhs.uk
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000002:abnormalities / Q000503:physiopathology; D015897:Comorbidity; D004565:Electroconvulsive Therapy; D006801:Humans; D008607:Intellectual Disability / Q000453:epidemiology* / Q000235:genetics / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D011618:Psychotic Disorders / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D012559:Schizophrenia / Q000453:epidemiology* / Q000503:physiopathology; D016896:Treatment Outcome
D014150:Antipsychotic Agents